Periodic Reporting for period 4 - ReGenHeart (Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory anginaA phase II randomized, double-blinded, placebo-controlled study)

What is the problem/issue being addressed?The most common symptom of coronary heart disease (CHD) is angina, chest pain, and within this group of patients refractory angina constitutes a serious clinical problem. The European Society of Cardiology has emphasised this important...